Rates of major or CRNM bleeding were significantly lower in apixaban-treated patients compared with enoxaparin/warfarin-treated patients
across BMI categories (Pinteraction = .55)
across BMI categories (Pinteraction = .55)
| BMI category | Apixaban n/N |
Enoxaparin/Warfarin n/N |
RR (95% CI) | P interaction |
|
|---|---|---|---|---|---|
| ≤25 kg/m2 | 35/725 | 60/711 |
|
0.58 (0.38-0.86) | .55 |
| >25 kg/m2 to 30 kg/m2 | 33/999 | 89/1029 |
|
0.38 (0.26-0.56) | |
| >30 kg/m2 to 35 kg/m2 | 29/575 | 64/587 |
|
0.46 (0.30-0.71) | |
| >35 kg/m2 to 40 kg/m2 | 12/236 | 29/206 |
|
0.35 (0.18-0.66) | |
| >40 kg/m2 | 5/126 | 17/137 |
|
0.32 (0.12-0.84) |
